Literature DB >> 7328611

Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.

A K Karim, M S Elfellah, D A Evans.   

Abstract

Acetylator phenotyping by means of a sulphadimidine tests revealed 65% of Libyan Arabs to be slow acetylators. Hence the frequency of the allele controlling slow acetylation (As) is estimated as q = 0.81 +/- 0.05. This estimate is similar to those previously recorded in European and adjacent Middle Eastern populations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7328611      PMCID: PMC1048751          DOI: 10.1136/jmg.18.5.325

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  44 in total

1.  [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].

Authors:  M LEHIR; J CHICOU; G HETRICK; A MERCIER; R NEEL; N RIST
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

2.  GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN, NEGRO, AND JAPANESE POPULATIONS.

Authors:  A P DUFOUR; R A KNIGHT; H W HARRIS
Journal:  Science       Date:  1964-07-24       Impact factor: 47.728

3.  [PROBLEMS OF ISONIAZID METABOLISM. HEREDITARY CHARACTER AND VARIABILITY ACCORDING TO RACES].

Authors:  S SUNAHARA; M URANO
Journal:  Med Thorac       Date:  1963

4.  FURTHER OBSERVATIONS ON TRIMODALITY OF FREQUENCY DISTRIBUTION CURVE OF BIOLOGICALLY ACTIVE ISONIAZID BLOOD LEVELS AND "CLINE" INFREQUENCIES OF ALLELES CONTROLLING ISONIAZID INACTIVATION.

Authors:  S SUNAHARA; M URANO; H T LIN; T J CHEG; A JARUMILINDA
Journal:  Acta Tuberc Pneumol Scand       Date:  1963

5.  Antinuclear factor in rapid and slow acetylator patients treated with isoniazid.

Authors:  D A Evans; M F Bullen; J Houston; C A Hopkins; J M Vetters
Journal:  J Med Genet       Date:  1972-03       Impact factor: 6.318

6.  Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).

Authors:  A Hanngren; O Borgå; F Sjöqvist
Journal:  Scand J Respir Dis       Date:  1970

7.  Comparison of the acetylation of procainamide and sulfadimidine in man.

Authors:  K Frislid; M Berg; V Hansteen; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

8.  The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients.

Authors:  M J Mattila; H Tiitinen
Journal:  Ann Med Exp Biol Fenn       Date:  1967

9.  Acetylation of sulfamethazine in a Nigerian population.

Authors:  L C Eze; O Obidoa
Journal:  Biochem Genet       Date:  1978-12       Impact factor: 1.890

10.  Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.

Authors:  K V Rao; D A Mitchison; N G Nair; K Prema; S P Tripathy
Journal:  Br Med J       Date:  1970-08-29
View more
  15 in total

1.  Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.

Authors:  Etienne Patin; Luis B Barreiro; Pardis C Sabeti; Frédéric Austerlitz; Francesca Luca; Antti Sajantila; Doron M Behar; Ornella Semino; Anavaj Sakuntabhai; Nicole Guiso; Brigitte Gicquel; Ken McElreavey; Rosalind M Harding; Evelyne Heyer; Lluis Quintana-Murci
Journal:  Am J Hum Genet       Date:  2006-01-13       Impact factor: 11.025

2.  Glucose-6-phosphate dehydrogenase deficiency and sulfadimidin acetylation phenotypes in Egyptian oases.

Authors:  L Hussein; G Yamamah; A Saleh
Journal:  Biochem Genet       Date:  1992-04       Impact factor: 1.890

3.  Ecogenetic studies in Atacameño Indians.

Authors:  H W Goedde; F Rothhammer; H G Benkmann; P Bogdanski
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology.

Authors:  H J Lin; C Y Han; B K Lin; S Hardy
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

5.  Association between phosphoglucomutase (PGM1) and group-specific component (Gc) subtypes and tuberculosis.

Authors:  S S Papiha; S S Agarwal; I White
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

6.  Acetylator phenotypes in Papua New Guinea.

Authors:  R J Penketh; S F Gibney; G T Nurse; D A Hopkinson
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

Review 7.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

Review 8.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 9.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

10.  The association of the slow acetylator phenotype with bladder cancer.

Authors:  D A Evans; L C Eze; E J Whibley
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.